Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) EPS (Weighted Average and Diluted) (2022 - 2025)

Historic EPS (Weighted Average and Diluted) for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to -$0.1.

  • Lucid Diagnostics' EPS (Weighted Average and Diluted) rose 6000.0% to -$0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.88, marking a year-over-year increase of 2212.39%. This contributed to the annual value of -$1.05 for FY2024, which is 1669.27% up from last year.
  • According to the latest figures from Q3 2025, Lucid Diagnostics' EPS (Weighted Average and Diluted) is -$0.1, which was up 6000.0% from -$0.08 recorded in Q2 2025.
  • Lucid Diagnostics' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.08 during Q2 2025, with a 5-year trough of -$0.52 in Q1 2025.
  • For the 4-year period, Lucid Diagnostics' EPS (Weighted Average and Diluted) averaged around -$0.3, with its median value being -$0.31 (2023).
  • Over the last 5 years, Lucid Diagnostics' EPS (Weighted Average and Diluted) had its largest YoY gain of 6521.74% in 2025, and its largest YoY loss of 3000.0% in 2025.
  • Quarter analysis of 4 years shows Lucid Diagnostics' EPS (Weighted Average and Diluted) stood at -$0.4 in 2022, then surged by 37.5% to -$0.25 in 2023, then increased by 8.61% to -$0.23 in 2024, then skyrocketed by 56.23% to -$0.1 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.1 for Q3 2025, versus -$0.08 for Q2 2025 and -$0.52 for Q1 2025.